Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve As Biomarkers of Lung Cancer-A Review

Overview

Journal Metabolites

Publisher MDPI

Date 2022 Jun 23

PMID 35736492

Authors

Saurin R Sutaria

Sadakatali S Gori

James D Morris

Zhenzhen Xie

Xiao-An Fu

Michael H Nantz

Affiliations

Soon will be listed here.

Abstract

The peroxidation of unsaturated fatty acids is a widely recognized metabolic process that creates a complex mixture of volatile organic compounds including aldehydes. Elevated levels of reactive oxygen species in cancer cells promote random lipid peroxidation, which leads to a variety of aldehydes. In the case of lung cancer, many of these volatile aldehydes are exhaled and are of interest as potential markers of the disease. Relevant studies reporting aldehydes in the exhaled breath of lung cancer patients were collected for this review by searching the PubMed and SciFinder databases until 25 May 2022. Information on breath test results, including the biomarker collection, preconcentration, and quantification methods, was extracted and tabulated. Overall, 44 studies were included spanning a period of 34 years. The data show that, as a class, aldehydes are significantly elevated in the breath of lung cancer patients at all stages of the disease relative to healthy control subjects. The type of aldehyde detected and/or deemed to be a biomarker is highly dependent on the method of exhaled breath sampling and analysis. Unsaturated aldehydes, detected primarily when derivatized during preconcentration, are underrepresented as biomarkers given that they are also likely products of lipid peroxidation. Pentanal, hexanal, and heptanal were the most reported aldehydes in studies of exhaled breath from lung cancer patients.

Citing Articles

Exploring Components, Sensors, and Techniques for Cancer Detection via eNose Technology: A Systematic Review.

Ramirez W, Pillajo V, Ramirez E, Manzano I, Meza D Sensors (Basel). 2024; 24(23).

PMID: 39686404 PMC: 11645018. DOI: 10.3390/s24237868.

Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection.

Golfinopoulou R, Hatziagapiou K, Mavrikou S, Kintzios S Sensors (Basel). 2024; 24(14).

PMID: 39066110 PMC: 11281049. DOI: 10.3390/s24144712.

Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.

Chou H, Godbeer L, Allsworth M, Boyle B, Ball M Metabolomics. 2024; 20(4):72.

PMID: 38977623 PMC: 11230972. DOI: 10.1007/s11306-024-02142-x.

Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breath.

Xie Z, Morris J, Pan J, Cooke E, Sutaria S, Balcom D Sci Rep. 2024; 14(1):14568.

PMID: 38914586 PMC: 11196736. DOI: 10.1038/s41598-024-61735-7.

Role of lingonberry press cake in producing stable herring protein isolates via pH-shift processing: A dose response study.

Zhang J, Hong B, Abdollahi M, Wu H, Undeland I Food Chem X. 2024; 22:101456.

PMID: 38808166 PMC: 11130683. DOI: 10.1016/j.fochx.2024.101456.

References

Koureas M, Kirgou P, Amoutzias G, Hadjichristodoulou C, Gourgoulianis K, Tsakalof A . Target Analysis of Volatile Organic Compounds in Exhaled Breath for Lung Cancer Discrimination from Other Pulmonary Diseases and Healthy Persons. Metabolites. 2020; 10(8). PMC: 7464039. DOI: 10.3390/metabo10080317. View

Corradi M, Folesani G, Andreoli R, Manini P, Bodini A, Piacentini G . Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med. 2002; 167(3):395-9. DOI: 10.1164/rccm.200206-507OC. View

Fu X, Li M, Knipp R, Nantz M, Bousamra M . Noninvasive detection of lung cancer using exhaled breath. Cancer Med. 2014; 3(1):174-81. PMC: 3930402. DOI: 10.1002/cam4.162. View

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

Schumer E, Black M, Bousamra 2nd M, Trivedi J, Li M, Fu X . Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection. Ann Thorac Surg. 2016; 102(4):1095-100. PMC: 5042568. DOI: 10.1016/j.athoracsur.2016.04.068. View

Schumer E, Trivedi J, van Berkel V, Black M, Li M, Fu X . High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds. J Thorac Cardiovasc Surg. 2015; 150(6):1517-22. DOI: 10.1016/j.jtcvs.2015.08.092. View

Chen X, Cao M, Hao Y, Li Y, Wang P, Ying K . A Non-invasive detection of lung cancer combined virtual gas sensors array with imaging recognition technique. Conf Proc IEEE Eng Med Biol Soc. 2007; 2005:5873-6. DOI: 10.1109/IEMBS.2005.1615826. View

Pelclova D, Zdimal V, Kacer P, Komarc M, Fenclova Z, Vlckova S . Markers of lipid oxidative damage among office workers exposed intermittently to air pollutants including nanoTiO2 particles. Rev Environ Health. 2016; 32(1-2):193-200. DOI: 10.1515/reveh-2016-0030. View

Bartoli M, Novelli F, Costa F, Malagrino L, Melosini L, Bacci E . Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm. 2011; 2011:891752. PMC: 3136125. DOI: 10.1155/2011/891752. View

10.

Corradi M, Pignatti P, Manini P, Andreoli R, Goldoni M, Poppa M . Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J. 2004; 24(6):1011-7. PMC: 1430385. DOI: 10.1183/09031936.04.00002404. View

11.

Deng C, Zhang X, Li N . Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 808(2):269-77. DOI: 10.1016/j.jchromb.2004.05.015. View

12.

Jafari M, Solhi E, Tagi S, Hasanzadeh M, Jouyban-Gharamaleki V, Jouyban A . Non-invasive quantification of malondialdehyde biomarker in human exhaled breath condensate using self-assembled organic-inorganic nanohybrid: A new platform for early diagnosis of lung disease. J Pharm Biomed Anal. 2018; 164:249-257. DOI: 10.1016/j.jpba.2018.10.048. View

13.

Posner G, ONeill P . Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides. Acc Chem Res. 2004; 37(6):397-404. DOI: 10.1021/ar020227u. View

14.

Peled N, Hakim M, Bunn Jr P, Miller Y, Kennedy T, Mattei J . Non-invasive breath analysis of pulmonary nodules. J Thorac Oncol. 2012; 7(10):1528-33. PMC: 3444531. DOI: 10.1097/JTO.0b013e3182637d5f. View

15.

Kyle J, Clair G, Bandyopadhyay G, Misra R, Zink E, Bloodsworth K . Cell type-resolved human lung lipidome reveals cellular cooperation in lung function. Sci Rep. 2018; 8(1):13455. PMC: 6128932. DOI: 10.1038/s41598-018-31640-x. View

16.

Feinberg T, Alkoby-Meshulam L, Herbig J, Cancilla J, Torrecilla J, Gai Mor N . Cancerous glucose metabolism in lung cancer-evidence from exhaled breath analysis. J Breath Res. 2016; 10(2):026012. DOI: 10.1088/1752-7155/10/2/026012. View

17.

Gaspar E, Lucena A, Duro da Costa J, Chaves das Neves H . Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders. J Chromatogr A. 2008; 1216(14):2749-56. DOI: 10.1016/j.chroma.2008.10.125. View

18.

Buszewski B, Ulanowska A, Kowalkowski T, Cieslinski K . Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics. Clin Chem Lab Med. 2011; 50(3):573-81. DOI: 10.1515/CCLM.2011.769. View

19.

Chen X, Muhammad K, Madeeha C, Fu W, Xu L, Hu Y . Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection. Lung Cancer. 2021; 154:197-205. DOI: 10.1016/j.lungcan.2021.02.006. View

20.

Van Gossum A, Decuyper J . Breath alkanes as an index of lipid peroxidation. Eur Respir J. 1989; 2(8):787-91. View